Although the U.S. healthcare industry has weathered the storm over the past couple of years, we may be reaching calmer waters in the coming months. Dry powder held by U.S. private equity investors has reached an all-time...more
8/15/2024
/ Acquisitions ,
Administrative Procedure Act ,
Corporate Transparency Act ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Federal Trade Commission (FTC) ,
Filing Requirements ,
Final Rules ,
Government Agencies ,
Hart-Scott-Rodino Act ,
Healthcare ,
Investment ,
Investors ,
Loper Bright Enterprises v Raimondo ,
Mergers ,
Non-Compete Agreements ,
Private Equity ,
Regulatory Authority ,
Request For Information ,
SCOTUS ,
Statutory Authority ,
Statutory Interpretation
On June 26, the California Senate Health Committee passed Assembly Bill 3129 (Bill), which was further amended on June 27 and re-referred to the Committee on Judiciary. The following is a summary of the material changes made...more
The 42nd annual J.P. Morgan Healthcare Conference started with clear skies and overall optimism from investors. But with Jamie Dimon’s prediction of a recession in 2024 on Tuesday morning, the climate shifted to an on-again,...more
1/12/2024
/ Acquisitions ,
Asset Diversification ,
Chapter 11 ,
Health Technology ,
Healthcare ,
Home Health Care ,
Hospice ,
Initial Public Offering (IPO) ,
Investors ,
JPMorgan Chase ,
Medicaid ,
Mental Health ,
Mergers ,
Pharmaceutical Industry ,
Reimbursements ,
Takeovers ,
Value-Based Care
W ith various headwinds resulting in down volume in 2023, buyers and sellers alike find themselves asking whether 2024 will see a rebound in deal activity. As we begin 2024, we have highlighted the issues and trends that...more
1/9/2024
/ Acquisitions ,
Artificial Intelligence ,
Corporate Transparency Act ,
Department of Justice (DOJ) ,
Diversity ,
Equity Markets ,
FinCEN ,
Funding ,
Healthcare ,
Investment ,
Investors ,
Mergers ,
Non-Compete Agreements ,
Pharmaceutical Industry ,
Popular ,
Privacy Laws ,
Private Equity ,
Reporting Requirements ,
Restrictive Covenants ,
Risk Management ,
Safe Harbors ,
Section 340B ,
Self-Disclosure Requirements ,
Value-Based Care
After steadying during Q2, it appears the overall volume of deals in the healthcare industry declined in Q3 compared with Q2, and year-to-date 2023 is still down from last year. A slumping economy has no doubt played a large...more
11/10/2023
/ Acquisitions ,
Ambulatory Surgery Centers ,
Digital Health ,
Health Care Providers ,
Health Information Technologies ,
Healthcare ,
Healthcare Facilities ,
Healthcare Reform ,
Home Health Care ,
Hospice ,
Hospitals ,
Legislative Agendas ,
Life Sciences ,
Managed Care Contracts ,
Mental Health ,
Mergers ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Physicians ,
Popular ,
Private Equity ,
Proposed Legislation ,
Regulatory Requirements ,
Sellers ,
Technology Sector ,
Telehealth
The healthcare M&A market appears to be steadying. Although deal activity through the year appears slightly below the high-water marks for the corresponding period of 2022, deal activity is generally up from the first quarter...more
7/28/2023
/ Acquisitions ,
Ambulatory Surgery Centers ,
Capital Markets ,
Digital Health ,
Domestic Dealmaking ,
Health Information Technologies ,
Healthcare ,
Home Health Care ,
Hospice ,
Hospitals ,
Investment ,
Investors ,
Life Sciences ,
Managed Care Contracts ,
Mergers ,
Pharmaceutical Industry ,
Physicians ,
Popular ,
Private Equity
Even the threat of an unprecedented atmospheric river storm could not stop the tried and true from attending the 41st annual J.P. Morgan Healthcare Conference. With a break of sunshine on Monday, we found ourselves asking,...more
1/13/2023
/ Acquisitions ,
Debt ,
Federal Trade Commission (FTC) ,
Funding ,
Healthcare ,
Investment ,
Investors ,
Mergers ,
Non-Compete Agreements ,
Private Equity ,
Proposed Rules
Although healthcare M&A activity in Q3 declined slightly from the previous quarter, analysts believe the activity level declined much less than expected given the numerous headwinds—inflation, rising interest rates, labor...more
11/22/2022
/ Acquisitions ,
Ambulatory Surgery Centers ,
Dental Practice ,
Digital Health ,
Health Information Technologies ,
Home Health Care ,
Hospice ,
Hospitals ,
Investment ,
Investors ,
Life Sciences ,
Managed Service Providers (MSPs) ,
Mental Health ,
Mergers ,
Pharmaceutical Industry ,
Physicians ,
Private Equity
Private equity investors’ interest in gastroenterology (GI) practices continues to remain strong, despite some headwinds that GI practices have experienced as a result of the COVID-19 pandemic and further investment in this...more
2020 was a tumultuous year for the healthcare industry, which continues to confront the effects of the COVID-19 pandemic. Despite these unprecedented and unpredictable times, healthcare merger and acquisition (M&A) activity...more
1/11/2021
/ Acquisitions ,
Ambulatory Surgery Centers ,
Coronavirus/COVID-19 ,
Health Care Providers ,
Health Information Technologies ,
Healthcare Facilities ,
Home Health Care ,
Hospice ,
Hospitals ,
Investors ,
Managed Care Contracts ,
Mergers ,
Pharmaceutical Industry ,
Physicians ,
Substance Abuse
By all accounts, 2019 proved to be another year of significant investment by private equity firms in the physician practice space. Below we discuss 10 trends we observed as counsel on a number of these transactions during...more
1/22/2020
/ Acquisitions ,
Commercial Insurance Policies ,
Contract Negotiations ,
Contract Terms ,
Due Diligence ,
Health Care Providers ,
Hospitals ,
Indemnity Insurance ,
Mergers ,
Partnerships ,
Physicians ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Strategic Planning
Discover the factors that drove healthcare M&A activity in 2019.
Innovation, expansion and continued private equity investment in the industry influenced healthcare transactions last year. 2019 saw continued robust...more
1/16/2020
/ Acquisitions ,
Ambulatory Surgery Centers ,
Centers for Medicare & Medicaid Services (CMS) ,
Divestiture ,
EBITDA ,
Health Care Providers ,
Health Information Technologies ,
Healthcare Facilities ,
Home Health Care ,
Hospice ,
Hospitals ,
Joint Venture ,
Managed Care Contracts ,
Medicare ,
Medicare Advantage ,
Mental Health ,
Mergers ,
Pharmacies ,
Physicians ,
Private Equity ,
Private Equity Firms
2018 marked a year of continued robust healthcare merger and acquisition activity, with deal volume surpassing that of 2017. The dollar volume of healthcare deals also exceeded 2017, highlighted by CVS Health Corp. (NYSE:...more
1/9/2019
/ Acquisitions ,
Acute Facilities ,
Ambulatory Surgery Centers ,
Health Care Providers ,
Health Information Technologies ,
Healthcare Facilities ,
Home Health Care ,
Hospice ,
Hospitals ,
Investors ,
Managed Care Contracts ,
Mergers ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Physicians ,
Private Equity ,
Private Equity Firms ,
Substance Abuse ,
Urgent Care Facilities
On December 3, 2017, CVS Health Corp. (NYSE: CVS) announced it would purchase health insurer Aetna Inc. (NYSE: AET) for $67.5 billion, a transaction that would be one of the biggest healthcare mergers in the past decade. The...more